...
首页> 外文期刊>Metabolism: Clinical and Experimental >Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
【24h】

Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.

机译:小鼠的肝胆固醇和胆汁酸合成,低密度脂蛋白受体功能以及血浆和粪便固醇水平:载脂蛋白E缺乏和普罗布考或植物甾醇治疗的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We compared hepatic cholesterol metabolism in apolipoprotein (apo) E-knockout (KO) mice with their wild-type counterparts. We also investigated the effects of treatment with phytosterols or probucol on the activity of hepatic 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase (cholesterol synthesis), cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase (bile acid synthesis), and low-density lipoprotein (LDL) receptor function in this animal model of atherogenesis. These findings were then related to treatment-induced changes in plasma, hepatic, and fecal sterol concentrations. Mouse liver membranes have binding sites similar to LDL receptors; the receptor-mediated binding represents 80% of total binding and is LDL concentration-dependent. These binding sites have higher affinity for apo E-containing particles than apo B only-containing particles. Deletion of apo E gene was associated with several-fold increases in plasma cholesterol levels, 1.5-fold increase in hepatic cholesterol concentrations, 50% decrease in HMG-CoA reductase activity, 30% increase in cholesterol 7 alpha-hydroxylase and 25% decrease in LDL receptor function. Treatment of apo E-KO mice with either probucol or phytosterols significantly reduced plasma cholesterol levels. Phytosterols significantly increased the activity of hepatic HMG-CoA reductase, and probucol significantly increased cholesterol 7 alpha-hydroxylase activity. Neither treatment significantly altered hepatic LDL receptor function. Phytosterols, but not probucol, significantly increased fecal sterol excretion and decreased hepatic cholesterol concentrations. Plasma cholesterol lowering effects of phytosterols and probucol are due to different mechanisms: stimulation of cholesterol catabolism via increased bile acid synthesis by probucol and decreased cholesterol absorption by phytosterols. In the absence of apo E, hepatic LDL receptors could not be upregulated and did not contribute to the cholesterol lowering effects of either agent. Copyright 2001 by W.B. Saunders Company
机译:我们比较了载脂蛋白(apo)电子敲除(KO)小鼠与野生型对应物的肝脏胆固醇代谢。我们还研究了植物甾醇或普罗布考对肝3-羟基-3-甲基-戊二酰辅酶A(HMG-CoA)还原酶(胆固醇合成),胆固醇7α-羟化酶和固醇27-羟化酶(胆汁)活性的影响酸合成)和低密度脂蛋白(LDL)受体在这种动脉粥样硬化动物模型中的功能。然后,这些发现与治疗引起的血浆,肝和粪便中甾醇浓度的变化有关。小鼠肝膜具有与LDL受体相似的结合位点。受体介导的结合占总结合的80%,并且是LDL浓度依赖性的。这些结合位点对仅含载脂蛋白B的颗粒具有更高的亲和力。载脂蛋白E基因的缺失与血浆胆固醇水平升高数倍,肝胆固醇浓度升高1.5倍,HMG-CoA还原酶活性降低50%,胆固醇7α-羟化酶升高30%和胆固醇降低25%有关。 LDL受体功能。用普罗布考或植物甾醇处理apo E-KO小鼠可显着降低血浆胆固醇水平。植物甾醇显着增加了肝脏HMG-CoA还原酶的活性,普罗布考显着增加了胆固醇7α-羟化酶的活性。两种治疗均未显着改变肝LDL受体功能。植物固醇(而非普罗布考)不会显着增加粪便固醇排泄并降低肝胆固醇浓度。植物甾醇和普罗布考降低血浆胆固醇的作用是由于不同的机制:通过丙丁酚的胆汁酸合成增加和植物甾醇对胆固醇的吸收降低而刺激胆固醇分解代谢。在缺乏载脂蛋白E的情况下,肝LDL受体不能被上调并且对任何一种药物的胆固醇降低作用没有贡献。 W.B.版权所有2001桑德斯公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号